Full Text | PDF

Share on tweeters Share on facebook Share on linkedin Share on googleplus

Nanotheranostics 2024; 8(2):127-149. doi:10.7150/ntno.92184 This issue Cite

Review

Nanoparticles for Thrombus Diagnosis and Therapy: Emerging Trends in Thrombus-theranostics

Samridhi1, Aseem Setia1, Abhishesh Kumar Mehata1, Vishnu Priya1, Aditi Pradhan1, Pragya Prasanna2, Syam Mohan3,4, Madaswamy S Muthu1✉

1. Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi-221005, India.
2. National Institute of Pharmaceutical Education and Research, Hajipur, Bihar, India.
3. Substance Abuse and Toxicology Research Centre, Jazan University, Jazan 45142, Saudi Arabia.
4. School of Health Sciences, University of Petroleum and Energy Studies, Dehradun 248007, India.

✉ Corresponding author: Department of Pharmaceutical Engineering and Technology, Indian Institute of Technology (BHU), Varanasi - 221005, India; Tel.: +91 9235195928; Fax: +91 542 2368428; E-mail: msmuthu.pheac.in (Madaswamy S. Muthu).

Citation:
Samridhi , Setia A, Mehata AK, Priya V, Pradhan A, Prasanna P, Mohan S, Muthu MS. Nanoparticles for Thrombus Diagnosis and Therapy: Emerging Trends in Thrombus-theranostics. Nanotheranostics 2024; 8(2):127-149. doi:10.7150/ntno.92184. https://www.ntno.org/v08p0127.htm
Other styles

File import instruction

Abstract

Graphic abstract

Cardiovascular disease is one of the chief factors that cause ischemic stroke, myocardial infarction, and venous thromboembolism. The elements that speed up thrombosis include nutritional consumption, physical activity, and oxidative stress. Even though the precise etiology and pathophysiology remain difficult topics that primarily rely on traditional medicine. The diagnosis and management of thrombosis are being developed using discrete non-invasive and non-surgical approaches. One of the emerging promising approach is ultrasound and photoacoustic imaging. The advancement of nanomedicines offers concentrated therapy and diagnosis, imparting efficacy and fewer side effects which is more significant than conventional medicine. This study addresses the potential of nanomedicines as theranostic agents for the treatment of thrombosis. In this article, we describe the factors that lead to thrombosis and its consequences, as well as summarize the findings of studies on thrombus formation in preclinical and clinical models and also provide insights on nanoparticles for thrombus imaging and therapy.

Keywords: thrombosis, pathophysiology, animal models, nanoparticles, imaging

Citation styles

APA
Samridhi, , Setia, A., Mehata, A.K., Priya, V., Pradhan, A., Prasanna, P., Mohan, S., Muthu, M.S. (2024). Nanoparticles for Thrombus Diagnosis and Therapy: Emerging Trends in Thrombus-theranostics. Nanotheranostics, 8(2), 127-149. https://doi.org/10.7150/ntno.92184.

ACS
Samridhi, ; Setia, A.; Mehata, A.K.; Priya, V.; Pradhan, A.; Prasanna, P.; Mohan, S.; Muthu, M.S. Nanoparticles for Thrombus Diagnosis and Therapy: Emerging Trends in Thrombus-theranostics. Nanotheranostics 2024, 8 (2), 127-149. DOI: 10.7150/ntno.92184.

NLM
Samridhi , Setia A, Mehata AK, Priya V, Pradhan A, Prasanna P, Mohan S, Muthu MS. Nanoparticles for Thrombus Diagnosis and Therapy: Emerging Trends in Thrombus-theranostics. Nanotheranostics 2024; 8(2):127-149. doi:10.7150/ntno.92184. https://www.ntno.org/v08p0127.htm

CSE
Samridhi , Setia A, Mehata AK, Priya V, Pradhan A, Prasanna P, Mohan S, Muthu MS. 2024. Nanoparticles for Thrombus Diagnosis and Therapy: Emerging Trends in Thrombus-theranostics. Nanotheranostics. 8(2):127-149.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.
Popup Image

©2024 Ivyspring International Publisher. Terms of use